China Care Atlas logo
China Care Atlas
  • Home
  • Hospitals
  • Treatments
  • Build My Plan
  • Guides
China Care Atlas logo
China Care Atlas

Compare top hospitals, advanced treatments, and transparent medical tourism information for China before you book travel.

Quick Links
HospitalsTreatmentsBuild My PlanGuides
Advanced Treatments
CAR-T & Cell TherapyProton & Heavy IonCardiovascular SurgeryComplex Neurosurgery
Legal
AboutContactHow We ResearchPrivacy PolicyTerms

2026 China Care Atlas. Advanced, Transparent Healthcare in China.

Advanced Clinical Pathway

Complex cardiovascular diseases

Chinese reference name: 复杂心血管疾病

World-leading cardiovascular surgical and interventional programs for complex aortic emergencies, structural heart valve disease, total coronary occlusions, and advanced heart failure.

Patient Candidacy & Fast Facts

Key Considerations for Patients

Suitable Conditions: Advanced or recurrent cases seeking breakthrough therapies approved in top clinical centers.
National Centers: Direct pathways across 2 leading tertiary hospitals with dedicated international wings.
Pre-Travel Review: Multidisciplinary team (MDT) case review available before international travel.
Evaluation Window
1–2 Weeks
Language Support
English Dedicated

Explore Related Clinical Specialties

Begin with Cardiovascular medicine, then compare the support departments that can affect diagnosis, intervention, and recovery planning.

Start: Cardiovascular medicineCardiac surgeryUltrasound medicineAnesthesiologyCritical care medicineRadiology

These links organize research only. They do not diagnose, refer, or confirm current case acceptance.

Personalized Treatment Planning

Sun's Procedure & Complex Structural Heart Pathway

Benchmark your condition, review clinical records needed for triage, and prepare your medical travel plan with leading centers.

Originator center for Sun's Procedure (total arch replacement + frozen elephant trunk)
Asia’s largest cardiovascular center with world-record low operative mortality
Advanced hybrid operating suites for simultaneous open & endovascular TEVAR
Pre-trip record checklistRequired for triage
  • Full-aorta CTA 3D contrast reconstruction DICOM
  • Transthoracic / transesophageal echocardiography (TTE/TEE)
  • Coronary angiography if available
Build Cardiovascular & Aortic Plan

Pre-selects Fuwai Hospital, CAMS & PUMC & relevant clinical criteria

Specialized Treatment Protocols

Target Indications & Qualified Hospital Capabilities

Explore clinical indications, treatment modalities, bed and ICU requirements, and patient eligibility criteria verified across leading tertiary centers.

4 Priority Pathways Verified
High-Priority Target#01

Stanford Type A Aortic Dissection & Arch Aneurysms

Stanford A型主动脉夹层与主动脉弓部动脉瘤

Target Stage & Goal: Tear or dilation involving the ascending aorta and aortic arch threatening rupture or coronary/cerebral malperfusion.

Hospitals with Verified Conditions to Treat This Disease:
Fuwai Hospital, CAMS & PUMC
中国医学科学院阜外医院Beijing · National Center for Cardiovascular Diseases (World Authority on Aortic Surgery)
Department of Vascular Surgery / International Medical Department
Hospital Facilities & Qualified Conditions:

Birthplace and global training authority for Sun's Procedure; 24/7 dedicated aortic emergency surgical team; state-of-the-art hybrid operating rooms with modern cardiopulmonary bypass (CPB) and selective cerebral perfusion.

Specific Treatment & Technology Offered:

Sun's Procedure (Total Aortic Arch Replacement with Frozen Elephant Trunk / 孙氏手术: 升主动脉置换+全主动脉弓替换+冷冻支架象鼻术).

Required Patient Eligibility Criteria:

CTA confirmed Acute or Subacute Stanford Type A dissection, or aortic arch aneurysm involving vital supra-aortic branches; patient hemodynamically stable or prepared for emergency surgical transfer.

Shanghai DeltaHealth Hospital
上海德达医院Shanghai · Specialized Cardiovascular Hospital (Partnered with Columbia HeartSource)
Heart Team International Clinic
Hospital Facilities & Qualified Conditions:

Headed by national leading thoracic aortic surgical masters, state-of-the-art hybrid vascular operating theaters, dedicated 20-bed cardiovascular surgical ICU, English-speaking clinical concierge.

Specific Treatment & Technology Offered:

Minimally Invasive Hybrid Aortic Arch Debranching & Frozen Elephant Trunk Stenting.

Required Patient Eligibility Criteria:

International or domestic patients seeking elective or urgent aortic arch reconstruction; stable peripheral organ perfusion.

High-Priority Target#02

Severe Calcified Aortic Stenosis & Complex Valvular Disease

重度钙化性主动脉瓣狭窄与复杂瓣膜病

Target Stage & Goal: Severe symptomatic aortic stenosis with heavy calcification, bicuspid morphology, or severe functional mitral/tricuspid regurgitation in high-risk surgical patients.

Hospitals with Verified Conditions to Treat This Disease:
Zhongshan Hospital, Fudan University
复旦大学附属中山医院Shanghai · National Pioneer in Structural Heart Disease
Department of Cardiology / Structural Heart Disease Program
Hospital Facilities & Qualified Conditions:

National pioneer center for transcatheter structural heart interventions; multi-detector CT valvular reconstruction laboratory; 3D transesophageal echocardiography (TEE) guided cath labs; ECMO emergency backup.

Specific Treatment & Technology Offered:

Transcatheter Aortic Valve Replacement (TAVR - specialized self-expanding and balloon-expandable valves tailored for heavy bicuspid calcification) & Transcatheter Edge-to-Edge Repair (TEER / MitraClip / DragonFly).

Required Patient Eligibility Criteria:

Severe symptomatic aortic stenosis (AVA <1.0 cm², mean gradient >40 mmHg) or severe mitral regurgitation (grade 3-4+); STS surgical risk score >8% or anatomical contraindication to open surgery; suitable femoral vascular anatomy.

Fuwai Hospital
北京阜外医院Beijing · National Reference Center for Valve Surgery
Cardiac Surgery Department
Hospital Facilities & Qualified Conditions:

National reference center performing >3,000 surgical valve procedures annually; thoracoscopic minimally invasive cardiac surgery suites.

Specific Treatment & Technology Offered:

Thoracoscopic Minimally Invasive Valve Repair / Bioprosthetic Replacement & Sutureless Valve Implantation.

Required Patient Eligibility Criteria:

Multivalvular disease, complex infective endocarditis, or rheumatic destruction; LVEF ≥30%.

Specialized Indication#03

End-Stage Heart Failure & Dilated Cardiomyopathy

终末期心力衰竭与扩张型心肌病

Target Stage & Goal: Refractory NYHA Class IV heart failure despite maximal medical therapy requiring permanent mechanical circulatory support or bridge-to-transplant.

Hospitals with Verified Conditions to Treat This Disease:
Fuwai Hospital
阜外医院Beijing · National Center for Cardiovascular Diseases
Heart Failure & Transplant Center
Hospital Facilities & Qualified Conditions:

National Heart Failure Clinical Medical Center, designated national ventricular assist device evaluation lead institution, dedicated mechanical circulatory support (MCS) intensive care unit.

Specific Treatment & Technology Offered:

Third-Generation Fully Magnetic Levitation Left Ventricular Assist Device (LVAD - Corheart 6 / HeartCon "Rocket Heart") Implantation as destination therapy or bridge-to-transplant.

Required Patient Eligibility Criteria:

NYHA Class IV heart failure despite optimal guideline-directed medical therapy; LVEF <25%; INTERMACS profile 2-4; absence of irreversible severe right ventricular failure or severe coagulation defects.

Specialized Indication#04

Complex Coronary Chronic Total Occlusion (CTO) & Left Main Disease (复杂冠脉慢性完全闭塞CTO与左主干病变)

Target Stage & Goal: Multi-vessel coronary artery disease with long-segment calcified chronic total occlusions refractory to standard catheterization.

Hospitals with Verified Conditions to Treat This Disease:
Fuwai Hospital & Zhongshan Hospital
Beijing / Shanghai · National Cardiovascular Benchmarks
Interventional Cardiology Division
Hospital Facilities & Qualified Conditions:

International training centers for complex CTO interventions; high-resolution intravascular ultrasound (IVUS), optical coherence tomography (OCT), intravascular lithotripsy (IVL 震波碎石) and coronary rotablation platforms; Impella percutaneous LVAD support.

Specific Treatment & Technology Offered:

Antegrade/Retrograde Wire Escalation CTO-PCI & Off-Pump Coronary Artery Bypass Grafting (OPCAB 心脏不停跳冠脉搭桥).

Required Patient Eligibility Criteria:

Severe refractory angina, documented myocardial ischemia; complex multi-vessel CAD; SYNTAX score >32 (evaluated by multidisciplinary Heart Team).

When This Option May Not Be Suitable

Situations Requiring Immediate Local Care or Where Travel Is Not Advised

Please evaluate these critical clinical exclusions before initiating cross-border medical consultations.

  • Acute cardiogenic shock with multi-organ failure where travel is immediately life-threatening.
  • Active severe systemic bacteremia or uncontrolled sepsis.
  • Severe irreversible non-cardiac organ disease (cirrhosis with ascites, dialysis-dependent renal failure without transplant plan).
Clinical Capabilities & Approvals

Key Clinical Milestones & Regulatory Status

Documented regulatory approvals, published clinical evidence, and capability standards verified across leading medical centers.

01

Verified capability

Fuwai Hospital performs the world's highest annual volume of complex aortic surgery, pioneering Sun's procedure with published operative mortality <3% in elective cohorts.

S14S31

02

Verified international access

DeltaHealth Hospital operates a dedicated international aortic surgery program with Columbia HeartSource partnership and bilingual emergency cardiac care.

S15S41S42
Qualified Hospital Directory

Leading Tertiary Centers & Advanced Offerings

Hospitals verified for clinical capability, advanced technology access, and international patient coordination pathways.

01

Institution in research

Fuwai Hospital (中国医学科学院阜外医院)

S14S31

Documented capability

Global authority in cardiac surgery, structural heart interventions, ventricular assist devices, and coronary revascularization.

International access

International Medical Services coordinates case evaluation, English diagnostic review, and planned elective inpatient admission.

Current editorial status

Direct patient intake for complex elective surgeries. Requires comprehensive cardiac CTA and echocardiography before travel.

View hospital details
Specific Advanced Treatments & Technologies Offered:
Complex Surgery & TransplantGlobal Pioneer Benchmark
Sun's Procedure (Total Arch Replacement + Frozen Elephant Trunk)
Target Indication:

Acute and chronic Stanford Type A aortic dissection, complex aortic arch aneurysms

Clinical Feature: Invented at Fuwai; eliminates false lumen in downstream thoracic aorta; proven long-term durability in >10,000 cases.

Minimally Invasive InterventionalNMPA Approved Commercial
Fully Magnetically Levitated LVAD Implantation (Corheart 6 / HeartCon)
Target Indication:

End-stage heart failure, refractory dilated cardiomyopathy

Clinical Feature: Ultra-compact 90g pump; minimal shear stress reducing hemolysis and bleeding events; destination therapy.

02

Institution in research

Shanghai DeltaHealth Hospital (上海德达医院)

S15S41S42

Documented capability

Premier cardiovascular center with Columbia HeartSource collaboration, specialized in aortic surgery, valve repair, and international care.

International access

Dedicated international appointment desk (+86 4008 210 277 / appointment@deltahealth.com.cn) with global insurance direct billing.

Current editorial status

Active intake for domestic and overseas cardiovascular patients. Fast-track second opinion and surgical scheduling.

View hospital details
Specific Advanced Treatments & Technologies Offered:
Complex Surgery & TransplantRoutine Clinical Center
Minimally Invasive Aortic Arch Surgery & Hybrid Stenting
Target Indication:

Thoracoabdominal aortic aneurysms, Stanford Type B complicated dissection, arch pathologies

Clinical Feature: Hybrid theater debranching techniques reducing cardiopulmonary bypass time; rapid post-op extubation.

Minimally Invasive InterventionalRoutine Clinical Center
Transcatheter Valve Repair & Replacement (TAVR / MitraClip)
Target Indication:

Aortic stenosis, severe mitral regurgitation in high-risk patients

Clinical Feature: Full-time international Heart Team, commercial insurance direct billing, bedside bilingual nursing.

Verified Public Intake Channels

Hospital Intake & Consultation Channels

Contact first, transmit identifiable medical records only through authorized hospital coordination desks.

2 Verified Hospital Channels

Fuwai Hospital International Medical Department

S31
Channel:+86 10 88398866 · inquiry +86 10 88322674
Known Use
Direct public switchboard and international surgical consultation inquiry
Patient Intake Advisory
Requires digital upload of recent contrast CTA and echocardiogram before confirming appointment.

Shanghai DeltaHealth Hospital Heart Team

S41S42
Channel:appointment@deltahealth.com.cn · +86 4008 210 277
Known Use
Specialized cardiovascular consultation, bilingual case coordination, and international insurance direct billing
Patient Intake Advisory
Direct liaison with Columbia HeartSource affiliated specialists; rapid surgical scheduling.
Medical Documentation Checklist

Essential Records to Prepare for Clinical Review

Having translated clinical records organized accelerates multidisciplinary evaluation and enables accurate treatment feasibility confirmation.

5 Required Clinical Documents
01

Full-body Aorta / Coronary Computed Tomography Angiography (CTA) with 3D reconstructions (DICOM discs)

02

Transthoracic and transesophageal echocardiography reports and digital loops (EF, valve gradients, regurgitant volumes)

03

Recent coronary angiogram catheterization reports and video files (if previous cath was performed)

04

Baseline organ function tests: Serum creatinine, liver enzymes, coagulation profile, and complete blood count

05

Recent ECG and 24-hour Holter monitoring reports (if arrhythmia is present)

Cost Breakdown & Financial Guidance

Transparent Breakdown of Treatment Stages & Cost Benchmarks

Documented Overall Cost Range & Benchmarks

Elective Sun's procedure total hospital cost ranges from 180,000 to 280,000 RMB in public centers. TAVR pathway ranges from 250,000 to 350,000 RMB. Advanced LVAD implantation ranges from 800,000 to 1,100,000 RMB.

Important Financial Notice

Device choices (imported vs domestic valves/implants), surgical complications, need for prolonged dialysis or ECMO support will directly affect the total bill.

Stage 1: Preoperative Cardiovascular Evaluation & Imaging

Scope: Comprehensive CTA re-evaluation, multi-view echocardiography, coronary angiogram if indicated, and Heart Team surgical risk scoring.

Financial Notes: Completed within 2-3 days of admission to determine precise surgical vs interventional approach.

Stage 2: Surgical Procedure / Device Implantation

Scope: Open cardiovascular surgery under cardiopulmonary bypass or cath-lab interventional implantation, including prostheses (frozen elephant trunk stent, TAVR valve, or LVAD pump).

Financial Notes: Hardware and device costs are significant (e.g. TAVR valve approx. 180,000 - 250,000 RMB, LVAD pump device approx. 600,000 - 800,000 RMB).

Stage 3: Cardiac Intensive Care

Scope: Postoperative mechanical ventilation, inotrope titration, continuous cardiac output monitoring, ECMO/IABP standby if needed, and chest tube management.

Financial Notes: Length of CICU stay varies (typically 2-5 days for uncomplicated cases, longer if severe pulmonary or renal backup needed).

Stage 4: Step-Down Ward Rehabilitation & Anticoagulation Stabilization

Scope: Cardiac rehabilitation mobilization, warfarin/NOAC international normalized ratio (INR) stabilization, repeat echo verification, and discharge planning.

Financial Notes: Prepares patient for commercial flight fitness (typically requires 14-21 days total post-op before long-distance air travel).

Cross-Border Travel & Continuity of Care

Travel Logistics, Hospital Stay & Long-Term Follow-up

Essential travel considerations, hospital stay durations, and follow-up safety protocols verified for international patients.

Pre-Travel & Inpatient

Before & During Travel

  • Commercial flight travel after major open-heart surgery requires clinical clearance (typically minimum 3-4 weeks post-op).
  • Patients receiving mechanical valves or LVADs must establish a reliable anticoagulation and device management clinic in their home country.
Post-Discharge Care

Follow-Up Requirements

  • Follow-up aorta/coronary CTA at 3 months and 12 months post-procedure
  • Regular INR monitoring for mechanical prostheses; regular driveline inspection for LVAD recipients
Safety Alert Triggers

Urgent Local-Care Triggers

  • Sudden tearing chest or back pain (emergency dissection sign)
  • Acute severe dyspnea, orthopnea, or pulmonary edema
  • Syncope, sustained tachyarrhythmia, or sudden neurological weakness
Ready to Take the Next Step?

Build Your Personalized Medical Travel Plan

Current international intake, elective-case boundaries, implant and ICU costs, flight fitness, anticoagulation, and post-discharge care Our planning engine benchmarks your medical records, outlines expected cost ranges, and prepares pre-travel intake questions for hospital international desks.

Build Cardiovascular & Aortic PlanBrowse All Qualified Hospitals
Clinical & Safety Boundaries

This overview is for medical planning and hospital matching. It does not replace individualized diagnosis by treating specialists. Final treatment plans, drug indications, and quotes must be issued directly by the admitting hospital.

Emergency Notice: Acute deterioration, unstable vital signs, or active severe infections require immediate local emergency care without delay.